Shanghai Pharmaceuticals (Germany) Top Insiders
S1R Stock | EUR 1.34 0.02 1.47% |
Shanghai Pharmaceuticals employs about 47.1 K people. The company is managed by 23 executives with a total tenure of roughly 104 years, averaging almost 4.0 years of service per executive, having 2045.91 employees per reported executive. Examination of Shanghai Pharmaceuticals' management performance can provide insight into the company performance.
Bo Shen President Chief Financial Officer, Vice President, Executive Director |
Shanghai |
Shanghai Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of 0.0281 % which means that it generated a profit of $0.0281 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1024 %, meaning that it generated $0.1024 on every $100 dollars invested by stockholders. Shanghai Pharmaceuticals' management efficiency ratios could be used to measure how well Shanghai Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Shanghai Pharmaceuticals Workforce Comparison
Shanghai Pharmaceuticals Holding is currently regarded as top stock in number of employees category among its peers. The total workforce of Medical Distribution industry is at this time estimated at about 49,856. Shanghai Pharmaceuticals totals roughly 47,056 in number of employees claiming about 94% of all equities under Medical Distribution industry.
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.04. Shanghai Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Shanghai Pharmaceuticals Price Series Summation is a cross summation of Shanghai Pharmaceuticals price series and its benchmark/peer.
Shanghai Pharmaceuticals Notable Stakeholders
A Shanghai Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Shanghai Pharmaceuticals often face trade-offs trying to please all of them. Shanghai Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Shanghai Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Bo Shen | Chief Financial Officer, Vice President, Executive Director | Profile | |
Jun Zhou | Chairman of the Board, Non-Executive Director | Profile | |
Dawei Liu | Vice President Secretary of the Board | Profile | |
Haoliang Gu | Vice President | Profile | |
Liang Hong | Independent Non-Executive Director | Profile | |
Ying Ke | Director Center | Profile | |
Yong Zhao | Vice President | Profile | |
Tao Zhong | Board VP | Profile | |
Jiangnan Cai | Independent Non-Executive Director | Profile | |
Man Cho | Pres Director | Profile | |
Shunjiang Yu | Chief Officer | Profile | |
Jianyi Mao | Vice President | Profile | |
Min Zuo | President Executive Director | Profile | |
Yaohua Zhang | Vice President | Profile | |
Chaoyang Gu | Independent Non-Executive Director | Profile | |
Yongzhong Li | Vice President Executive Director | Profile | |
Jinzhu Chen | Secretary of the Board | Profile | |
Wenxun Huo | Independent Non-Executive Director | Profile | |
An Li | Non-Executive Director | Profile | |
Jinqi Yu | G Mang | Profile | |
Dawei Ge | Vice Chairman of the Board, Non-Executive Director | Profile | |
Shui ACS | Joint Sec | Profile | |
Linqiong Dong | Securities Representative | Profile |
About Shanghai Pharmaceuticals Management Performance
The success or failure of an entity such as Shanghai Pharmaceuticals often depends on how effective the management is. Shanghai Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Shanghai management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Shanghai management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the Peoples Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical Co., Ltd. SHANGHAI PHARM operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 46609 people.
Shanghai Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Shanghai Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Shanghai Pharmaceuticals within its industry.Shanghai Pharmaceuticals Manpower Efficiency
Return on Shanghai Pharmaceuticals Manpower
Revenue Per Employee | 4.6M | |
Revenue Per Executive | 9.4B | |
Net Income Per Employee | 108.2K | |
Net Income Per Executive | 221.5M |
Complementary Tools for Shanghai Stock analysis
When running Shanghai Pharmaceuticals' price analysis, check to measure Shanghai Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Pharmaceuticals is operating at the current time. Most of Shanghai Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Shanghai Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Pharmaceuticals' price. Additionally, you may evaluate how the addition of Shanghai Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |